Lab to Impact: Healthcare Module – From Bench to Market: Navigating the Complex Landscape of Drug Commercialization

Join the Center for Technology Licensing for a dynamic panel on the real-world path from innovation to therapeutic impact.

You’ll hear from biotech executives and academic leaders as they explore the drug commercialization process—from regulatory planning to market access, and the obstacles and opportunities in between.

What to expect:

• Key insights into regulatory and market access strategy
• Lessons from successful therapeutic launches
• Real-world examples of collaboration and adaptation

Guest speakers: 

• Alexander Brown, COO of Convergent Therapeutics
• Dr. Neil Bander, CSO, Co-Founder of Convergent Therapeutics
• Dr. Philip Kantoff, CEO, Co-Founder of Convergent Therapeutics
• Dr. Scott Tagawa, Professor of Medicine in Urology at Weill Cornell Medicine

  Hosted by Brian Kelly, Director of Technology Licensing, CTL at Weill Cornell Medicine

Whether you’re considering a new idea, commercialization, or actively developing a technology, this event offers valuable perspectives on turning promising research into market-ready solutions.